Conference Call and Webcast to Follow
WASHINGTON, July 20,
2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc.
(Vanda) (Nasdaq: VNDA) today announced it will release results for
the second quarter 2023 on Thursday, July
27, 2023, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Thursday, July 27, 2023, during which management
will discuss the second quarter 2023 financial results and other
corporate activities. To participate in the conference call, please
dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international)
and use passcode 4063687.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Thursday, July 27, 2023, beginning at
8:30 PM ET and will be accessible
until Thursday, August 3, 2023, at
8:30 PM ET. The replay call-in number
is 1-800-770-2030 for domestic callers and 1-609-800-9909 for
international callers. The passcode number is 4063687.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
Kevin
Moran
Senior Vice President, Chief Financial Officer and
Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-second-quarter-2023-financial-results-on-july-27-2023-301882530.html
SOURCE Vanda Pharmaceuticals Inc.